Artelo Biosciences/ US04301G1022 /
2024-06-05 3:30:00 PM | Chg. +0.06 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
1.45USD | +3.94% | 2 Turnover: 2.90 |
-Bid Size: - | -Ask Size: - | 1.45 | 1.45 |
GlobeNewswire
06-04
Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of ...
GlobeNewswire
05-29
Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12....
GlobeNewswire
05-13
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
04-23
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising ...
GlobeNewswire
04-22
Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM East...
GlobeNewswire
03-25
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
GlobeNewswire
03-12
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
GlobeNewswire
01-23
Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating AR...
GlobeNewswire
01-08
Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organizatio...
GlobeNewswire
2023-12-05
Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Con...
GlobeNewswire
2023-11-30
Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Canna...
GlobeNewswire
2023-11-13
Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-11-09
Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Prop...
GlobeNewswire
2023-11-02
Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxie...
GlobeNewswire
2023-10-04
Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H....
GlobeNewswire
2023-09-13
Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th
GlobeNewswire
2023-09-07
Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12
GlobeNewswire
2023-09-06
Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12...
GlobeNewswire
2023-09-05
Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on Sep...
Newsfile Corp
2022-04-26
Artelo Biosciences to Present at Investor Summit Group's Q2 In-Person Conference in New York
Newsfile Corp
2022-04-25
Artelo Biosciences to Present at Investor Summit Group's Q2 In-Person Conference in New York